US Stock MarketDetailed Quotes

SGMO Sangamo Therapeutics

Watchlist
  • 0.955
  • +0.080+9.14%
Trading Mar 6 15:15 ET
199.24MMarket Cap-1.34P/E (TTM)

Sangamo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

EPS
According to the latest financial report of Sangamo Therapeutics, the latest earnings per share (TTM) for the company is 0.04. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

Loading...

FCF
Interested in knowing about Sangamo Therapeutics's free cash flow? The latest report shows it as 11.64M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Loading...

Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Sangamo Therapeutics shows that the company's current ratio is 1.35, indicating healthy liquidity.

Currency: USD

Quarterly

Loading...

Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Sangamo Therapeutics, the quick ratio is 1.15, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

Loading...

ROE
Want to learn more about the financial health of Sangamo Therapeutics? The latest ROE figure is 29.88%, indicating that the company has stable profitability.

Currency: USD

Quarterly

Loading...

ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Sangamo Therapeutics, the total asset return on investment (ROA) is 9.19%.

Currency: USD

Quarterly

Loading...

Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Sangamo Therapeutics's latest financial report to see how their gross margin is doing - currently at 100.00%.

Currency: USD

Quarterly

Loading...

Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Sangamo Therapeutics, the net profit margin is 21.60%, which is a good sign for its profitability.

Currency: USD

Quarterly

Loading...

Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Intchains Group
ICG
+3.98%
Argo Blockchain
ARBK
+0.70%
Digihost Technology
DGHI
+0.36%
Strategy
MSTR
-0.54%
MARA Holdings
MARA
-0.79%

Unlock the Full List

Investment Theme Gene Editing
Gene Editing
Intraday-0.81%